GlobeNewswire
ImageneBio to Participate in Leerink Global Healthcare Conference
📊
AI Sentiment
Positive
6/10
- Home
- IMA
IMA
ImageneBio Inc.
as of 02-27-2026 2:38pm EST
$6.85
+$0.02
+0.23%
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 65.4M | IPO Year: | N/A |
| Target Price: | $16.00 | AVG Volume (30 days): | 45.4K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $5.70 - $17.50 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -92.3% | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Latest ImageneBio Inc. News
IMA Breaking Stock News: Dive into IMA Ticker-Specific Updates for Smart Investing
Compare IMA vs Leading Stocks
See how IMA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IMA ImageneBio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.